AACR Journal Cancer Discovery Receives Prestigious 2011 PROSE Award
PHILADELPHIA — The American Association for Cancer Research’s newest journal, Cancer Discovery, has received a 2011 American Publishers Award for Professional and Scholarly Excellence (PROSE Award). Cancer Discovery received this award for “Best New Journal in Science, Technology and Medicine.”
The Professional and Scholarly Publishing (PSP) Division of the Association of American Publishers presented more than 45 PROSE awards at a special awards luncheon, which was held recently during the PSP Annual Conference in Washington, D.C.
“The American Association for Cancer Research is honored to receive this accolade for its newest addition, Cancer Discovery, to our robust publications program,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “This award solidifies the journal’s reputation as an influential publication in the industry. Through the expert guidance of its outstanding editors-in-chief, Cancer Discovery brings top-rated research articles to the scientific and medical community, and we are very proud that it has received this early recognition for its contributions to the cancer literature.”
“All of us who are involved with the publishing of Cancer Discovery are extremely pleased to receive such an esteemed award,” said the journal’s publisher Diane Scott-Lichter. “Cancer Discovery captures the most significant work in cancer research and provides a unique forum to communicate and inspire new thinking in the field.”
Cancer Discovery launched at the AACR 102nd Annual Meeting 2011 and is the seventh journal published by the AACR. The journal provides readers with high-impact, peer-reviewed articles describing major advances in basic, translational, clinical and epidemiological research. It features game-changing research, review articles, perspectives and commentaries, news, and “Research Watch” summaries of important journal articles.
In addition, Cancer Discovery combines the expertise and experience of founding Editors-in-Chief Lewis C. Cantley, Ph.D., director of the cancer center and chief of the division of signal transduction at Beth Israel Deaconess Medical Center, and professor of systems biology at Harvard Medical School, and José Baselga, M.D., Ph.D., chief of the division of hematology/oncology and associate director of the Massachusetts General Hospital Cancer Center, and professor of medicine at Harvard Medical School.
The 2011 PROSE Awards received a record-breaking 512 entries — more than ever before in its 36-year history — from more than 60 professional and scholarly publishers across the country. Award recipients were determined by a distinguished panel of 14 PROSE judges. A full list of the award recipients and video highlights from this year’s awards luncheon can be found at www.proseawards.com.
For more information on Cancer Discovery, please visit http://cancerdiscovery.aacrjournals.org.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review and scientific oversight of individual and team science grants in cancer research that have the potential for patient benefit. The AACR actively communicates with legislators and policy makers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.